Elekta and GE Healthcare Join Forces to Increase Access to Radiation Therapy

The relationship between GE Healthcare and Elekta has many benefits for hospitals in developing and rising nations and rural hospitals in the United States. The two firms seek to increase access to radiation therapy, leading to better outcomes and saving lives. Continue reading for further information. First, however, what is the purpose of this partnership? Let's investigate the science that underlies it.

GE Health Care

GE Healthcare is an innovative multinational firm specializing in medical technology, pharmaceutical diagnostics, and digital solutions. They aim to assist physicians in making better judgments in less time and advance patient-centred care and precision medicine. In addition, GE Healthcare collaborates with prestigious academic institutions and startup companies to enhance the development of cancer immunotherapies. To do this, the companies have developed some new partnerships and products that can assist in accelerating the pace of cancer research.

Elekta

The partnership between GE Healthcare and Elekta will provide cancer patients with a comprehensive suite of radiation oncology options. GE Healthcare's radiation oncology solutions consist of CT scanners, PET simulators, MRI systems, and ultrasound imaging equipment. These methods assist physicians in locating malignancies and administering radiation therapy to them. The combined portfolios of radiation therapy will increase the quality of care and save lives.

The Cambridge University

The two firms established partnerships in digital oncology, radiogenic analysis, and infrastructure for integrated data management. As a result, the organizations will increase access to the most recent advances and support integrated healthcare systems. By forming these partnerships, GE Healthcare can diagnose and treat cancer patients with greater precision and sensitivity. Such solutions are now under development by businesses. Visit Elekta to discover more about the partnership.

Mirada Medical

GE Healthcare and Elekta have established a global commercial partnership in which they will develop a comprehensive offering for cancer centres and hospitals that includes flexible simulation technologies and innovative radiation therapy solutions. In addition, the two companies will develop AI and automation in medical imaging and radiation therapy by working together. The combination of two portfolios will allow cancer centres and hospitals to give patients the most precise and cost-efficient treatment possible.

ANIE biomarker platform

GE Healthcare and Elekta have formed global business cooperation in the field of radiation oncology. Together, they will provide a single radiation treatment option for cancer patients. The agreement between the companies aims to fulfil the increasing need for flexible simulation and interoperable guidance technology in developed countries. Through the relationship, they can also provide individual solutions to other vendors.

Auto-contouring system by Visioneer; VBrain

Britain, a treatment for brain tumours powered by artificial intelligence and recently cleared by the FDA, is now available. The method enables a more exact mapping of brain tumours through more frequent and smaller incisions. Additionally, data routing is supported. The technology's AI-powered features would allow physicians to use it for diagnostic and treatment planning.

Emeka

In increasing, demand is radiation oncology solutions. Through a recent statement, GE Healthcare and Elekta have combined their imaging and radiation therapy offerings. Together, these businesses will give a holistic solution to hospitals that addresses the needs of cancer patients worldwide. The arrangement will increase the number of hospitals worldwide with access to both companies' goods and provide individual solutions for additional vendors. In addition, it will boost the interoperability of both firms' systems.

Sophia GENETICS

GE Healthcare and SOPHiA GENETICS established a partnership to increase access to cancer treatment. The two businesses will collaborate on developing artificial intelligence-powered workflow and analytics products. Together, they will integrate GE's broad medical imaging capabilities and Edison-enabled data aggregation with Sophia Genetics' cloud-based genetic insights analytics platform. In addition, the agreement will enable the companies to collaborate and recruit pilot sites for their technology solutions.

Comments

Popular posts from this blog

The Advantages of Image-Guided Radiotherapy Systems

Optimizing Radiation Oncology Treatment Planning Efficiency